CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Sees Potential in Alternative Nicotine Delivery Method
Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) believes that its patented technology, DehydraTECH™ has the potential to transform nicotine use by offering a delivery method that may be an effective alternative to the traditional inhalation. An article discussing the company reads: “Although inhalation is an effective delivery mechanism – much more so than non-enhanced edible ingestion – it is dangerous. The toxins released during combustion are harmful and can potentially kill the user. Edible ingestion eliminates the toxins caused by lighting up. While inhalation is fast, traditionally, ingestion has not been. However, the use of DehydraTECH™ speeds things up to make…